347 related articles for article (PubMed ID: 34726531)
21. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features.
Sun Z; Hu S; Ge Y; Wang J; Duan S; Song J; Hu C; Li Y
J Xray Sci Technol; 2020; 28(3):449-459. PubMed ID: 32176676
[TBL] [Abstract][Full Text] [Related]
22. MRI-based radiomics analysis in differentiating solid non-small-cell from small-cell lung carcinoma: a pilot study.
Dang S; Guo Y; Han D; Ma G; Yu N; Yang Q; Duan X; Duan H; Ren J
Clin Radiol; 2022 Oct; 77(10):e749-e757. PubMed ID: 35817610
[TBL] [Abstract][Full Text] [Related]
23. Radiomics with Artificial Intelligence for the Prediction of Early Recurrence in Patients with Clinical Stage IA Lung Cancer.
Shimada Y; Kudo Y; Maehara S; Amemiya R; Masuno R; Park J; Ikeda N
Ann Surg Oncol; 2022 Dec; 29(13):8185-8193. PubMed ID: 36070112
[TBL] [Abstract][Full Text] [Related]
24. Discovery of pre-therapy 2-deoxy-2-
Arshad MA; Thornton A; Lu H; Tam H; Wallitt K; Rodgers N; Scarsbrook A; McDermott G; Cook GJ; Landau D; Chua S; O'Connor R; Dickson J; Power DA; Barwick TD; Rockall A; Aboagye EO
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):455-466. PubMed ID: 30173391
[TBL] [Abstract][Full Text] [Related]
25. Radiomics Signature: A Biomarker for the Preoperative Distant Metastatic Prediction of Stage I Nonsmall Cell Lung Cancer.
Fan L; Fang M; Tu W; Zhang D; Wang Y; Zhou X; Xia Y; Li Z; Liu S
Acad Radiol; 2019 Sep; 26(9):1253-1261. PubMed ID: 30527455
[TBL] [Abstract][Full Text] [Related]
26. Oncological outcomes of sublobar resection for clinical-stage IA high-risk non-small cell lung cancer patients with a radiologically solid appearance on computed tomography.
Hattori A; Takamochi K; Matsunaga T; Oh S; Suzuki K
Gen Thorac Cardiovasc Surg; 2016 Jan; 64(1):18-24. PubMed ID: 26486132
[TBL] [Abstract][Full Text] [Related]
27. Development of a radiomics nomogram based on the 2D and 3D CT features to predict the survival of non-small cell lung cancer patients.
Yang L; Yang J; Zhou X; Huang L; Zhao W; Wang T; Zhuang J; Tian J
Eur Radiol; 2019 May; 29(5):2196-2206. PubMed ID: 30523451
[TBL] [Abstract][Full Text] [Related]
28. CT radiomics-based model for predicting TMB and immunotherapy response in non-small cell lung cancer.
Wang J; Wang J; Huang X; Zhou Y; Qi J; Sun X; Nie J; Hu Z; Wang S; Hong B; Wang H
BMC Med Imaging; 2024 Feb; 24(1):45. PubMed ID: 38360550
[TBL] [Abstract][Full Text] [Related]
29. CT-based radiomics for predicting brain metastases as the first failure in patients with curatively resected locally advanced non-small cell lung cancer.
Sun F; Chen Y; Chen X; Sun X; Xing L
Eur J Radiol; 2021 Jan; 134():109411. PubMed ID: 33246270
[TBL] [Abstract][Full Text] [Related]
30. Impact of tumor size on survival in stage IA non-small cell lung cancer: a case for subdividing stage IA disease.
Gajra A; Newman N; Gamble GP; Abraham NZ; Kohman LJ; Graziano SL
Lung Cancer; 2003 Oct; 42(1):51-7. PubMed ID: 14512187
[TBL] [Abstract][Full Text] [Related]
31. Multiregional radiomics of brain metastasis can predict response to EGFR-TKI in metastatic NSCLC.
Fan Y; Wang X; Dong Y; Cui E; Wang H; Sun X; Su J; Luo Y; Yu T; Jiang X
Eur Radiol; 2023 Nov; 33(11):7902-7912. PubMed ID: 37142868
[TBL] [Abstract][Full Text] [Related]
32. CT-based radiomics signature to predict CD8+ tumor infiltrating lymphocytes in non-small-cell lung cancer.
Chen Y; Xu T; Jiang C; You S; Cheng Z; Gong J
Acta Radiol; 2023 Apr; 64(4):1390-1399. PubMed ID: 36120843
[TBL] [Abstract][Full Text] [Related]
33. Intratumoral and peritumoral radiomics nomograms for the preoperative prediction of lymphovascular invasion and overall survival in non-small cell lung cancer.
Chen Q; Shao J; Xue T; Peng H; Li M; Duan S; Feng F
Eur Radiol; 2023 Feb; 33(2):947-958. PubMed ID: 36064979
[TBL] [Abstract][Full Text] [Related]
34. Computer-aided diagnosis of distal metastasis in non-small cell lung cancer by low-dose CT based radiomics and deep learning signatures.
Song X; Duan X; He X; Wang Y; Li K; Deng B; Chen X; Wang Y; Li M; Shan H
Radiol Med; 2024 Feb; 129(2):239-251. PubMed ID: 38214839
[TBL] [Abstract][Full Text] [Related]
35. Development and Validation of a Machine Learning Model to Explore Tyrosine Kinase Inhibitor Response in Patients With Stage IV EGFR Variant-Positive Non-Small Cell Lung Cancer.
Song J; Wang L; Ng NN; Zhao M; Shi J; Wu N; Li W; Liu Z; Yeom KW; Tian J
JAMA Netw Open; 2020 Dec; 3(12):e2030442. PubMed ID: 33331920
[TBL] [Abstract][Full Text] [Related]
36. CT-based radiomics signatures can predict the tumor response of non-small cell lung cancer patients treated with first-line chemotherapy and targeted therapy.
Yang F; Zhang J; Zhou L; Xia W; Zhang R; Wei H; Feng J; Zhao X; Jian J; Gao X; Yuan S
Eur Radiol; 2022 Mar; 32(3):1538-1547. PubMed ID: 34564744
[TBL] [Abstract][Full Text] [Related]
37. Survival after surgery for pathologic stage IA non-small cell lung cancer associated with idiopathic pulmonary fibrosis.
Saito Y; Kawai Y; Takahashi N; Ikeya T; Murai K; Kawabata Y; Hoshi E
Ann Thorac Surg; 2011 Nov; 92(5):1812-7. PubMed ID: 21944440
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Impact of Very Small Ground-Glass Opacity Component in Stage IA Solid Predominant Non-small Cell Lung Cancer.
Hattori A; Matsunaga T; Fukui M; Suzuki K; Takamochi K; Suzuki K
Semin Thorac Cardiovasc Surg; 2024 Summer; 36(2):251-260. PubMed ID: 36180013
[TBL] [Abstract][Full Text] [Related]
39. Artificial intelligence-based radiomics for the prediction of nodal metastasis in early-stage lung cancer.
Shimada Y; Kudo Y; Maehara S; Fukuta K; Masuno R; Park J; Ikeda N
Sci Rep; 2023 Jan; 13(1):1028. PubMed ID: 36658301
[TBL] [Abstract][Full Text] [Related]
40. Outcome prediction in resectable lung adenocarcinoma patients: value of CT radiomics.
Choe J; Lee SM; Do KH; Kim S; Choi S; Lee JG; Seo JB
Eur Radiol; 2020 Sep; 30(9):4952-4963. PubMed ID: 32356158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
